RESUMO
OBJECTIVE: Colorectal cancer, one of the most frequently diagnosed cancers worldwide, has a high mortality rate. Thus, our research aims to examine the preventive effects of diosmin (DIO) alone and in conjunction with the anti-cancer drug irinotecan (camptothecin-11, CPT-11), on 1,2-dimethylhydrazine (DMH)-induced colon cancer (CC) in male Wistar rats. MATERIALS AND METHODS: Fifty adult male Wistar rats were categorized into five groups. Group I (Normal) received saline 0.9 orally % as a vehicle once a week for 14 weeks. Group II (DMH) received DMH (20 mg/kg/week) orally dissolved in 0.9% saline for 14 weeks and 1% carboxymethylcellulose (CMC) every other day for the final 10 weeks. Group III (DMH+DIO) received DMH orally for 14 weeks and DIO (10 mg/kg, suspended in 1% CMC) every other day for the final 10 weeks. Group IV (DMH+CPT-11) received DMH orally for 14 weeks and intraperitoneal injection of CPT-11 (3 mg/kg) twice a week for the final 10 weeks. Group V (DMH+DIO+CPT-11) orally received DMH for 14 weeks and both DIO and CPT-11. RESULTS: All treated groups showed a significant reduction (p<0.05) in their elevated serum malondialdehyde levels and significant amelioration (p<0.05) of their lowered activities of colon glutathione-S-transferase (GST) and glutathione reductase (GR) as well as serum glutathione level (GSH). In addition, simultaneous treatment with DIO and CPT-11 led to a significant decrease (p<0.05) in the elevated serum levels of carcinoembryonic antigen (CEA) in rats administered with DMH, as well as a reduction in the colon expression levels of the inflammatory mediator (NF-κB), cell proliferator protein (Ki-67), and proapoptotic protein (p53). CONCLUSIONS: These findings suggest DIO, CPT-11, and their combination have anticarcinogenic effects against DMH-induced CC by suppressing oxidative stress, simulating the antioxidant defense system, attenuating the inflammatory effects, and reducing cell proliferation.
Assuntos
1,2-Dimetilidrazina , Neoplasias do Colo , Diosmina , Irinotecano , Ratos Wistar , Animais , Masculino , Neoplasias do Colo/induzido quimicamente , Neoplasias do Colo/tratamento farmacológico , Neoplasias do Colo/patologia , Neoplasias do Colo/prevenção & controle , Neoplasias do Colo/metabolismo , Ratos , Diosmina/farmacologia , Diosmina/administração & dosagem , Irinotecano/farmacologia , Irinotecano/administração & dosagem , Camptotecina/análogos & derivados , Camptotecina/farmacologia , Estresse Oxidativo/efeitos dos fármacosRESUMO
Colorectal cancer (CRC) is a major cause of cancer-related deaths worldwide, underscoring the importance of understanding the diverse molecular and genetic underpinnings of CRC to improve its diagnosis, prognosis, and treatment. This review delves into the adenoma-carcinoma-metastasis model, emphasizing the "APC-KRAS-TP53" signature events in CRC development. CRC is categorized into four consensus molecular subtypes, each characterized by unique genetic alterations and responses to therapy, illustrating its complexity and heterogeneity. Furthermore, we explore the role of chronic inflammation and the gut microbiome in CRC progression, emphasizing the potential of targeting these factors for prevention and treatment. This review discusses the impact of dietary carcinogens and lifestyle factors and the critical role of early detection in improving outcomes, and also examines conventional chemotherapy options for CRC and associated challenges. There is significant focus on the therapeutic potential of flavonoids for CRC management, discussing various types of flavonoids, their sources, and mechanisms of action, including their antioxidant properties, modulation of cell signaling pathways, and effects on cell cycle and apoptosis. This article presents evidence of the synergistic effects of flavonoids with conventional cancer therapies and their role in modulating the gut microbiome and immune response, thereby offering new avenues for CRC treatment. We conclude by emphasizing the importance of a multidisciplinary approach to CRC research and treatment, incorporating insights from genetic, molecular, and lifestyle factors. Further research is needed on the preventive and therapeutic potential of natural compounds, such as flavonoids, in CRC, underscoring the need for personalized and targeted treatment strategies.
Assuntos
Neoplasias do Colo , Flavonoides , Humanos , Flavonoides/farmacologia , Flavonoides/uso terapêutico , Animais , Neoplasias do Colo/tratamento farmacológico , Neoplasias do Colo/patologia , Neoplasias do Colo/prevenção & controle , Microbioma Gastrointestinal/efeitos dos fármacosRESUMO
BACKGROUND: Colorectal cancer (CRC) is the third leading cause of cancer and the second cause of cancer-related deaths in the world. Despite the infrastructure and the availability of organized screening programs, participation in their screening programs is less than the set goals. Considering the importance of informing the society about the prevention and early detection of colorectal cancer symptoms and the positive impact of mobile health technologies, the present research was conducted with the aim of designing and evaluating a colon cancer mobile application. METHODS: The present research was conducted in two phases: software design and evaluation. In the first phase, the software was prepared using the cascade method. First, all the educational content related to colorectal cancer was collected through an expert panel with the participation of 10 specialists. Then the software was evaluated with alpha and beta testing, and the initial version was approved by users in terms of simplicity and usability. In the second phase, a parallel clinical randomized trial study was conducted with the aim of investigating the effect of a colon cancer mobile application on the early detection of colorectal cancer. In this stage, 204 volunteers participated; inclusion criteria were age 18-85 years, owning a smartphone and the ability to read and write. Participants were randomized into control and intervention groups. The intervention group was educated with the colon cancer application for education about colorectal cancer, and the control group was educated with a pamphlet. After education, both groups were screened for colorectal cancer symptoms, and the results were compared. RESULTS: In the software evaluation phase, the application was used by 204 users. In this stage, 84 (41.2%) women and 120 (58.8%) men, with an average (Standard Deviation) age of 47.53 (13.68) participated. Participants were randomized in two groups, 103 people with an average (Standard Deviation) age of 47.62 (14.65) in intervention group and 101 people with an average (Standard Deviation) age of 47.44 (12.70) in control group. There were no significant differences between the demographic characteristics of age, gender, marriage, occupation, instruction level, digestive disease history, cancer history, cancer risk factors, and family history of cancer between the two groups (P > 0.05). The Mann-Whitney U test indicated that there is a significant difference between the two groups of participants in self-assessment, willingness to do the screening, and the results of the assessment of colorectal cancer (P < 0.05). CONCLUSION: The results of the research indicated the positive impact of the Colon Cancer Application on the abilities of the users of self-assessment of colon cancer. Therefore, based on the findings, it can be concluded that the use of the colon cancer mobile application is effective for colon cancer prevention and self-care. TRIAL REGISTRATION: This study was registered in the Iranian Registry of Clinical Trials ( https://irct.behdasht.gov.ir ) on 13/2/2024, with the IRCT ID: IRCT20210131050189N9.
Assuntos
Detecção Precoce de Câncer , Aplicativos Móveis , Humanos , Pessoa de Meia-Idade , Detecção Precoce de Câncer/métodos , Masculino , Feminino , Idoso , Adulto , Design de Software , Neoplasias Colorretais/diagnóstico , Neoplasias Colorretais/prevenção & controle , Idoso de 80 Anos ou mais , Neoplasias do Colo/diagnóstico , Neoplasias do Colo/prevenção & controle , Adulto Jovem , Adolescente , Educação de Pacientes como AssuntoRESUMO
Colorectal cancer (CRC) accounts for 30% of all cancer cases worldwide and is the second leading cause of cancer-related deaths. CRC develops over a long period of time, and in the early stages, pathological changes can be mitigated through nutritional interventions using bioactive plant compounds. Our study aims to determine the effect of highly purified oat beta-glucan on an animal CRC model. The study was performed on forty-five male Sprague-Dawley rats with azoxymethane-induced early-stage CRC, which consumed feed containing 1% or 3% low molar mass oat beta-glucan (OBG) for 8 weeks. In the large intestine, morphological changes, CRC signaling pathway genes (RT-PCR), and proteins (Western blot, immunohistochemistry) expression were analyzed. Whole blood hematology and blood redox status were also performed. Results indicated that the histologically confirmed CRC condition led to a downregulation of the WNT/ß-catenin pathway, along with alterations in oncogenic and tumor suppressor gene expression. However, OBG significantly modulated these effects, with the 3% OBG showing a more pronounced impact. Furthermore, CRC rats exhibited elevated levels of oxidative stress and antioxidant enzyme activity in the blood, along with decreased white blood cell and lymphocyte counts. Consumption of OBG at any dose normalized these parameters. The minimal effect of OBG in the physiological intestine and the high activity in the pathological condition suggest that OBG is both safe and effective in early-stage CRC.
Assuntos
Avena , Suplementos Nutricionais , Estresse Oxidativo , Ratos Sprague-Dawley , beta-Glucanas , Animais , Masculino , beta-Glucanas/farmacologia , beta-Glucanas/administração & dosagem , Avena/química , Ratos , Estresse Oxidativo/efeitos dos fármacos , Neoplasias do Colo/prevenção & controle , Anticarcinógenos/farmacologia , Azoximetano , Via de Sinalização Wnt/efeitos dos fármacos , Modelos Animais de Doenças , Ração Animal , Colo/patologia , Colo/efeitos dos fármacos , Colo/metabolismo , Neoplasias Colorretais/prevenção & controle , Antioxidantes/farmacologiaAssuntos
Neoplasias do Colo , Detecção Precoce de Câncer , Humanos , Polônia/epidemiologia , Neoplasias do Colo/diagnóstico , Neoplasias do Colo/epidemiologia , Neoplasias do Colo/prevenção & controle , Detecção Precoce de Câncer/métodos , Programas de Rastreamento/métodos , Programas de Rastreamento/normasRESUMO
INTRODUCTION: Recently published studies support the beneficial effects of consuming fibre-rich legumes, such as cooked dry beans, to improve metabolic health and reduce cancer risk. In participants with overweight/obesity and a history of colorectal polyps, the Fibre-rich Foods to Treat Obesity and Prevent Colon Cancer randomised clinical trial will test whether a high-fibre diet featuring legumes will simultaneously facilitate weight reduction and suppress colonic mucosal biomarkers of colorectal cancer (CRC). METHODS/DESIGN: This study is designed to characterise changes in (1) body weight; (2) biomarkers of insulin resistance and systemic inflammation; (3) compositional and functional profiles of the faecal microbiome and metabolome; (4) mucosal biomarkers of CRC risk and (5) gut transit. Approximately 60 overweight or obese adults with a history of noncancerous adenomatous polyps within the previous 3 years will be recruited and randomised to one of two weight-loss diets. Following a 1-week run-in, participants in the intervention arm will receive preportioned high-fibre legume-rich entrées for two meals/day in months 1-3 and one meal/day in months 4-6. In the control arm, entrées will replace legumes with lean protein sources (eg, chicken). Both groups will receive in-person and written guidance to include nutritionally balanced sides with energy intake to lose 1-2 pounds per week. ETHICS AND DISSEMINATION: The National Institutes of Health fund this ongoing 5-year study through a National Cancer Institute grant (5R01CA245063) awarded to Emory University with a subaward to the University of Pittsburgh. The study protocol was approved by the Emory Institutional Review Board (IRB approval number: 00000563). TRIAL REGISTRATION NUMBER: NCT04780477.
Assuntos
Pólipos Adenomatosos , Neoplasias do Colo , Fabaceae , Microbioma Gastrointestinal , Adulto , Humanos , Sobrepeso/complicações , Sobrepeso/terapia , Obesidade/complicações , Obesidade/terapia , Neoplasias do Colo/prevenção & controle , Pólipos Adenomatosos/complicações , Verduras , Metaboloma , Biomarcadores , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
El cáncer colorrectal presenta un problema para la salud pública a nivel mundial. En Argentina, se diagnostican aproximadamente 13.500 casos cada año. El tamizaje como medida de prevención secundaria es una medida beneficiosa para lograr un abordaje temprano con mejores resultados. Los dos métodos más utilizados para el tamizaje son la videocolonoscopía y la prueba de sangre oculta en materia fecal, sobre todo la de tipo inmunoquímico que con el paso de los años fue reemplazando a la prueba de guayaco por su mayor practicidad. El primero es un método invasivo y que requiere anestesia, mientras que el segundo no tiene un efecto adverso directo pero debe realizarse con una cadencia mayor. El objetivo de los autores de este artículo fue evaluar la evidencia sobre la sensibilidad y especificidad de ambos métodos, como también sus beneficios y daños a partir de la consulta de un paciente a su médico de familia. Ninguna prueba parecería ser inferior para el tamizaje de cáncer colorrectal en una población de riesgo promedio, y ambas pueden usarse en programas de rastreo. Sin embargo, no existen estudios que comparen ambos métodos de manera directa, y toda prueba inmunoquímica fecal positiva debe ser seguida de una colonoscopía. La elección de la prueba puede depender de los valores y preferencias de los pacientes. (AU)
Colorectal cancer presents a public health problem worldwide. In Argentina, approximately 13,500 cases appear each year. Screening as a secondary prevention measure is a beneficial measure to achieve an early approach with better results. The two most used methods for screening are video colonoscopy and faecal immunochemical test, the former being invasiveand requiring anaesthesia, while the latter does not have a direct adverse effect but must be performed at a higher rate. The objective of this article was to evaluate the evidence for the sensitivity and specificity of both methods, as well as their benefits and harms. No test would appear to be inferior for colorectal cancer screening in an average-risk population, and both can be used in screening programs. However, there are no studies comparing both methods directly, and any positive faecal immunochemical test should be evaluated with a colonoscopy. The choice of the test may depend on the values and preferences of the patients. (AU)
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias do Colo/prevenção & controle , Detecção Precoce de Câncer/métodos , Participação do Paciente , Programas de Rastreamento/métodos , Metanálise como Assunto , Saúde Pública , Sensibilidade e Especificidade , Colonoscopia/estatística & dados numéricos , Detecção Precoce de Câncer/efeitos adversos , Prevenção Secundária/métodos , Preferência do Paciente , Revisões Sistemáticas como Assunto , Sangue OcultoRESUMO
Objetivos: Evaluar el efecto protector del aceite de Sacha Inchi (ASI) sobre el desarrollo de cáncer de colon (CC) inducido con 1,2dimetilhidrazina (DMH) en ratas Holtzman. Materiales y métodos: Estudio experimental con 28 ratas albinas machos de la cepa Holtzman distribuidas al azar en 4 grupos: un grupo control positivo expuesto a DMH (C1), un grupo control negativo expuesto a ASI a 150 μL/kg/día (C2), y dos grupos experimentales expuestos a DMH con ASI a 150 μL/kg/día (E1) y ASI a 300 μL/kg/día (E2). La DMH se aplicó por 8 semanas y con un tiempo total de inducción de 22 semanas. Luego se realizó el análisis patológico mediante la identificación de lesiones tumorales cancerosas en los intestinos. El efecto protector se evaluó en base a las proporciones de ausencia de lesión en los grupos expuestos a DMH. Resultados: Se identificaron lesiones tumorales cancerosas en: dos especímenes del grupo C1, un espécimen del grupo E1 y dos especímenes del grupo E2. No se identificaron lesiones intestinales en el grupo C2. Las proporciones de ausencia de lesión fueron: en el grupo C1 de 75%, en el grupo E1 de 87,5% y en el grupo E2 de 75%. No se encontraron diferencias significativas (p>0,05). Conclusiones: No se evidenció un efecto protector significativo del ASI sobre el desarrollo de CC inducido con DMH en ratas Holtzman, respecto al grupo control.
Objectives: To evaluate the preventive effect of Sacha Inchi oil (SIO) on 1,2dimethylhydrazine (DMH)-induced colon carcinogenesis (CC) in Holtzman rats. Materials and methods: Experimental study with 28 Holtzman male albino rats randomly distributed into 4 groups: a positive control group exposed to DMH (C1), a negative control group exposed to SIO at 150 uL/kg/ day (C2), and two experimental groups exposed to DMH with SIO at 150 uL/kg/day (E1) and SIO at 300 uL/kg/day (E2). The DMH was applied for 8 weeks and the total induction time was 22 weeks. Pathological examination was performed by identifying cancerous tumor lesions in the guts. The preventive effect was evaluated based on proportions of lack of lesion in the groups exposed to DMH. Results: Cancerous tumor lesions were identified in: two specimens of group C1, one specimen of group E1 and two specimens of group E2. No intestinal lesions were identified in group C2. The proportions of lack of lesion were: in group C1 of 75%, in group E1 of 87.5% and group E2 of 75%. No significant differences were found (p>0.05). Conclusions: It was not found a significant protective effect of SIO on DMH-induced CC in Holtzman rats, compared to control group.
Assuntos
Animais , Masculino , Ratos , Óleos de Plantas/uso terapêutico , Adenocarcinoma/prevenção & controle , Neoplasias do Colo/prevenção & controle , Euphorbiaceae , Fitoterapia , Adenocarcinoma/induzido quimicamente , Adenocarcinoma/patologia , Distribuição Aleatória , Resultado do Tratamento , Ratos Sprague-Dawley , Neoplasias do Colo/induzido quimicamente , Neoplasias do Colo/patologia , 1,2-DimetilidrazinaRESUMO
RESUMEN Objetivos Determinar la toxicidad y el efecto quimioprotector del extracto alcaloideo de Melocactus bellavistensis (cactus globoso) sobre el cáncer de colon inducido en ratas con 1,2 dimetilhidrazina (DMH). Materiales y métodos Se obtuvo el extracto alcaloideo de la parte carnosa de Melocactus bellavistensis, posteriormente, se realizó un ensayo de toxicidad aguda en 30 ratones de cepas Balb C57. Para evaluar su efecto quimioprotector se indujo el cáncer de colon en 45 ratas Holtzmann con DMH, según el siguiente diseño experimental: un grupo control con: polisorbato de sodio (PS) a 2 mL/kg y cuatro grupos con DMH 20 mg/kg más 0, 1, 5 y 10 mg/kg de extracto alcaloideo de Melocactus bellavistensis respectivamente. Resultados Con una muestra de 5 g de extracto alcaloideo se determinó una DL50 mayor a 1000 mg/mL en el ensayo de toxicidad aguda del extracto alcaloideo de Melocactus bellavistensis. Los resultados del efecto quimioprotector en los indicadores de estudio histopatológico revelaron que a las dosis de 5 y 10 mg/kg demostraron actividad antitumoral significativa en el cáncer de colon inducido por dimetilhidrazina en ratas con 100% de inhibición de neoplasia. Conclusiones En condiciones experimentales, el extracto de alcaloides de Melocactus bellavistensis demostró tener efecto quimioprotector en cáncer de colon inducido por dimetilhidrazina en ratas.
ABSTRACT Objectives To determine the toxicity and chemoprotective effect of the alkaloid extract of Melocactus bellavistensis against colon cancer induced in rats using 1,2-dimethylhydrazine (DMH). Materials and methods The alkaloid extract was obtained from the fleshy part of M. bellavistensis, and an acute toxicity test was then carried out on 30 mice of the Balb C57 strain. To assess its chemoprotective effect, colon cancer was induced in 45 Holtzman rats using DMH according to the following experimental design: one control group received 2 mL/kg sodium polysorbate, and four groups received 20 mg/kg DMH plus 0, 1, 5, or 10 mg/kg M. bellavistensis alkaloid extract. Results With a sample of 5 g of alkaloid extract, an LD50 greater than 1000 mg/mL was determined in the acute toxicity test. Histological indicators revealed that the 5 and 10 mg/kg doses had significant anti-tumor activity with 100% neoplasia inhibition against DMH- induced colon cancer in rats. Conclusions Under experimental conditions, the alkaloid extract of M. bellavistensis has a chemoprotective effect against DMH-induced colon cancer in rats.
Assuntos
Animais , Ratos , Extratos Vegetais/uso terapêutico , Neoplasias do Colo/prevenção & controle , Cactaceae , Fitoterapia , Ratos Sprague-Dawley , Neoplasias do Colo/complicações , 1,2-Dimetilidrazina/administração & dosagem , Alcaloides/uso terapêuticoRESUMO
ANTECEDENTES: La detección y resección de lesiones colónicas plipoideas, sésiles y planas, previene el desarrollo de cáncer de colon. La mucosectomía endoscópica ha surgido en 1970 como un procedimiento alternativo para el tratamiento de éstas lesiones y, en la actualidad, es considerado el procedimiento de elección, pudiendo evitar procedimientos quirúrgicos mayores. OBJETIVO: Evaluar los resultados y complicaciones de la técnica de mucosectomía realizada por cirujanos coloproctólogos. Con revisión de indicaciones y limitaciones de la técnica. MATERIAL Y MÉTODO: Se realizó un análisis descriptivo, retrospectivo y observacional de pacientes tratados con técnica de mucosectomía endoscópica en el Servicio de Coloproctología del Hospital Británico de Bs. As., desde junio de 2010 a junio 2015. Se aplicó la técnica de elevación y corte en lesiones polipoideas mayores a 1 cm. Se realizó la resección en bloque para aquellas lesiones de hasta 3 cm y, para aquellas mayores a los 3 cm, se utilizó la resección por técnica de piecemeal. Se evaluaron complicaciones y resultados según la técnica empleada al igual que tasa de recidiva, realizando en todos los casos seguimiento con control endoscópico. RESULTADOS: Se analizaron un total de 41 casos (25 mujeres y 16 hombres) realizándose un procedimiento por paciente. La edad promedio fue de 65,8 años (38-83 años) y el tamaño promedio de las lesiones de 20,3 mm (10 50 mm). Se realizó resección en bloque en 19 pacientes (representando el46,3% de nuestra serie) y logrando resección endoscópica y anatomopatológica completa en todos ellos. En tanto se empleó técnica de piecemeal en los 22 pacientes restantes (53,6%). La tasa de complicaciones en nuestra serie fue del 7,3% (3/41). El seguimiento promedio fue de 14,4 meses (2 48 meses) y la tasa global de recidiva local fue de 9,75%...
BACKGROUND: Detection and resection of colonic lesions polypoid sessile and flat, prevents the development of colon cancer. Endoscopic mucosal resection has emerged in 1970 as an alternative method for the treatment of these lesions and, at present it is considered the procedure of choice, being able to avoid major surgical procedures. Objectives evaluation of the results and complications of the technique mucosectomy by colorectal surgeons. Review of indications and limitations of the technique. MATERIAL AND METHODS: Descriptive, retrospective and observational analysis of patients treated with endoscopic mucosal resection technique in the Coloproctology Service of the British Hospital of Buenos Aires, from June 2010 to June 2015. Technique of "lift and cut" was used in polypoid lesions greater than 1 cm. The bloc resection is used for those injuries up to 3 cm, and the piecemeal resection technique was used for those older than 3 cm. Complications and results were evaluated according to the technique as recurrence rate , performing tracking in all cases with endoscopic control. RESULTS: forty one cases (25 women and 16 men) performing a procedure per patient were analyzed. The average age was 65.8 years (38-83 years) and the average lesion size of 20.3 mm (10-50 mm). The average age was 65.8 years (38-83 years) and the average lesion size of 20.3 mm (10-50 mm). Resection was performed in 19 patients block (representing the 46.3 % of our series) and achieving endoscopic resection and pathologic complete in all. Piecemeal technique was used in the remaining 22 patients (53.6 %). The complication rate in our series was 7.3% (3/41). Mean follow-up was 14.4 months (2-48 months) and overall local recurrence rate was 9.75%...
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Neoplasias do Colo/prevenção & controle , Pólipos do Colo/patologia , Pólipos do Colo/cirurgia , Mucosa Intestinal/patologia , Mucosa Intestinal/cirurgia , Argentina , Colonoscopia/métodos , Endoscopia/métodos , Epidemiologia Descritiva , Estudos Observacionais como Assunto , Cuidados Pós-Operatórios , Complicações Pós-Operatórias , Cuidados Pré-Operatórios , Estudos RetrospectivosRESUMO
El objetivo del estudio fue determinar los conocimientos de los familiares sobre las medidas preventivas en cáncer de colon en el servicio de oncología del Hospital Militar Central 2014. Material y Método: El estudio es de nivel aplicativo, tipo cuantitativo, método descriptivo de corte transversal. La población estuvo conformada por 30 familiares. La técnica fue la encuesta y el instrumento un cuestionario aplicado previo consentimiento informado. Resultados: Del 100 por ciento (30), 53 por ciento (16) no conoce y 47 por ciento (14) conoce. En relación a los conocimientos de los familiares en la dimensión prevención primaria, 60 por ciento (18) no conoce y 40 por ciento (12) conoce. Mientras que en la dimensión prevención secundaria, 67 por ciento (20) no conoce y 33 por ciento (10) conoce. Conclusiones: El mayor porcentaje de familiares de pacientes con cáncer de colon, no conocen sobre la edad para descartar cáncer de colon, la frecuencia para realizar actividad física, prueba recomendable, el consumo de carnes ahumadas, la definición de biopsia y manifestaciones de cáncer de colon; seguido de un porcentaje considerable de familiares que conocen los factores de riesgo de cáncer de colon, el signo característico del cáncer de colon, medidas para disminuir riesgos de cáncer y los alimentos que aumentan el riesgo de cáncer de colon, que hacer en caso de cáncer de un familiar, y los motivos para la realización de colonoscopia...
The objective of the study was to determine knowledge of family members on preventive measures in colon cancer in the 2014 Central Military Hospital Oncology service. Material and Method: The study is application level, quantitative, descriptive cross-sectional method. The population was formed by 30 relatives. The technique was the survey and the instrument a questionnaire applied prior informed consent. Results: 100 per cent (30), 53 per cent (16) not known and 47 per cent (14) meet. In relation to the knowledge of relatives in the primary prevention dimension, 60 per cent (18) does not know and 40 per cent (12) meet. While in the secondary prevention dimension, 67 per cent (20) does not know and 33 per cent (10) meet. Conclusions: The highest percentage of relatives of patients with colon cancer, don't know about the age to rule out colon cancer, the frequency to perform recommended physical activity, the consumption of smoked meats, the definition of biopsy and manifestations of colon cancer; followed by a considerable percentage of family members who know the risk factors for colon cancer, the hallmark of colon cancer, measures to reduce risks of cancer and foods that increase the risk of colon cancer, that make cancer of a family member, and the reasons for the realization of colonoscopy...
Assuntos
Humanos , Masculino , Adulto , Feminino , Adulto Jovem , Pessoa de Meia-Idade , Conhecimento , Cuidadores , Enfermagem Oncológica , Neoplasias do Colo/prevenção & controle , Prevenção de Doenças , Estudos de Avaliação como Assunto , Estudos TransversaisRESUMO
La porción comestible del mango contiene ácido ascórbico, carotenoides, polifenoles, terpenoides y fibra que tienen efectos protectores para la salud, y posiblemente contra el desarrollo de cáncer de colon (CCO). El objetivo de este estudio fue evaluar la capacidad antiproliferativa en células de adenocarcinoma de colon (SW480) y preventiva en un modelo in vivo de CCO de un extracto acuoso de Mangifera indica cv. Azúcar. El contenido de fenoles totales, flavonoides y carotenoides también fue analizado. El extracto inhibió el crecimiento de las células SW480 en forma dosistiempo- dependiente hasta 22,3% luego de 72h de exposición al extracto (200 μg/mL). La carcinogénesis en el colon de ratones Balb/c fue inducida mediante dos inyecciones intraperitoneales de azoximetano (AOM) a la tercera y cuarta semana de haber iniciado el suministro de mango en el líquido de bebida (0,3%, 0,6%, 1,25%). Después de 10 semanas de tratamiento se observó inhibición dosis-dependiente de la formación de focos de criptas aberrantes (FCA); 0,3% de mango inhibió más del 60% de FCA (p=0,05) comparado con los controles que recibieron agua. Estos resultados muestran que la pulpa del mango de azúcar, un alimento natural, no tóxico, que forma parte de la dieta del ser humano contiene compuestos bioactivos capaces de reducir el crecimiento de células tumorales y prevenir la aparición de las lesiones precancerosas en colon durante el inicio de la carcinogénesis.
Mango pulp contains ascorbic acid, carotenoids, polyphenols, terpenoids and fiber which are healthy and could protect against colon cancer. The aim of this study was to evaluate the antiproliferative and preventive capacity of an aqueous extract of Mangifera indica cv. Azúcar on a human colon adenocarcinoma cell line (SW480) and in a rodent model of colorectal cancer, respectively. The content of total phenolics, flavonoids and carotenoids were also analyzed in the extract. SW480 cell growth was inhibited in a dose and time dependent manner by 22.3% after a 72h exposure to the extract (200 μg/ mL). Colon carcinogenesis was initiated in Balb/c mice by two intra-peritoneal injections of azoxymethane (AOM) at the third and fourth week of giving mango in drinking water (0.3%, 0.6%, 1.25%). After 10 weeks of treatment, in the colon of mice receiving 0.3% mango, aberrant crypt foci formation was inhibited more than 60% (p=0,05) and the inhibition was dose-dependent when compared with controls receiving water. These results show that mango pulp, a natural food, non toxic, part of human being diet, contains bioactive compounds able to reduce growth of tumor cells and to prevent the appearance of precancerous lesions in colon during carcinogenesis initiation.
Assuntos
Animais , Masculino , Anticarcinógenos/farmacologia , Neoplasias do Colo/prevenção & controle , Mangifera/química , Extratos Vegetais/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Transformação Celular Neoplásica/efeitos dos fármacos , Neoplasias do Colo/induzido quimicamente , Técnicas In Vitro , Camundongos Endogâmicos BALB C , Neoplasias ExperimentaisRESUMO
PURPOSE: To investigate the hemopreventive effect of defatted flaxseed meal in C57BL/6 mice after induction of precancerous colon lesions with 1.2-dimethylhydrazine (DMH). METHODS: Thirty-six 12-week-old C57BL/6 mice were divided into three treatment groups(n=12 in each group): (1) diet with 10% defatted flaxseed meal; (2) diet with defatted flaxseed meal and precancerous colon lesions induced by DMH; and (3) precancerous colon lesions induced by DMH, without defatted flaxseed meal. The incidence of aberrant crypt foci (ACF), oxidative processes, expression of tumor suppressor proteins and cyclins, as well as the profile of short-chain fatty acids (SCFA) in animal feces were investigated in the presence and absence of DMH. RESULTS: The rats consuming defatted flaxseed meals showed lesions with lower multiplicity and a reduced incidence of lesions. No changes in the expression of tumor suppressor proteins and those involved in cell cycle control were detected. CONCLUSION: Defatted flaxseed meal protected the distal colon of mice from precancerous lesions.
Assuntos
Animais , Camundongos , Colo/lesões , Neoplasias do Colo/prevenção & controle , Linho/química , Extratos Vegetais/farmacologia , Lesões Pré-Cancerosas/prevenção & controle , Sementes/química , Focos de Criptas Aberrantes , Carcinógenos , Neoplasias do Colo/induzido quimicamente , Ácidos Graxos/análise , Estresse Oxidativo , Lesões Pré-Cancerosas/induzido quimicamente , Reação em Cadeia da Polimerase em Tempo Real , Reprodutibilidade dos Testes , Fatores de TempoRESUMO
PURPOSE: To determine the effect of probiotics on the development of chemically induced (1, 2-dimethylhydrazine) colonic preneoplastic lesions, in mice. METHODS: The animals were divided into five groups. The control group was injected with carcinogen alone and the other groups also received probiotics (1- Lactobacillus delbrueckii UFV-H2b20; 2- Bifidobacterium animalis var. lactis Bb12; 3- L. delbrueckii UFV-H2b20 plus B. animalis var. lactis Bb12; and 4- Saccharomyces boulardii) administered orally in drinking water throughout fourteen weeks. RESULTS: Consumption of lactobacilli and bifidobacteria alone resulted in a significant reduction of the total number of aberrant crypt foci (55.7% and 45.1%, respectively). Significant reduction in the number of these small foci (<3 aberrant crypts) was only observed in the group treated with lactobacilli (52.2%) in comparison to control group. The number of larger foci (>3 aberrant crypts) crypts had no significant reduction. CONCLUSION: L. delbrueckii UFV-H2b20 and B. animalis var. lactis Bb12 administered alone protect colonic preneoplastic lesions in mice, while the combined treatment of these bacteria and the administration of S.boulardii were not effective in reducing such colonic lesions.
Assuntos
Animais , Masculino , Camundongos , Focos de Criptas Aberrantes/prevenção & controle , Neoplasias do Colo/prevenção & controle , Lesões Pré-Cancerosas/prevenção & controle , Probióticos/farmacologia , Focos de Criptas Aberrantes/induzido quimicamente , Focos de Criptas Aberrantes/patologia , Bifidobacterium/fisiologia , Carcinógenos , Terapia Combinada , Neoplasias do Colo/induzido quimicamente , Neoplasias do Colo/patologia , Dimetilidrazinas , Lactobacillus delbrueckii/fisiologia , Lesões Pré-Cancerosas/induzido quimicamente , Lesões Pré-Cancerosas/patologia , Reprodutibilidade dos Testes , Saccharomyces/fisiologia , Fatores de TempoRESUMO
Sericin is a silk protein woven from silkworm cocoons (Bombyx mori). In animal model, sericin has been reported to have anti-tumoral action against colon cancer. The mechanisms underlying the activity of sericin against cancer cells are not fully understood. The present study investigated the effects of sericin on human colorectal cancer SW480 cells compared to normal colonic mucosal FHC cells. Since the size of the sericin protein may be important for its activity, two ranges of molecular weight were tested. Sericin was found to decrease SW480 and FHC cell viability. The small sericin had higher anti-proliferative effects than that of the large sericin in both cell types. Increased apoptosis of SW480 cells is associated with increased caspase-3 activity and decreased Bcl-2 expression. The anti-proliferative effect of sericin was accompanied by cell cycle arrest at the S phase. Thus, sericin reduced SW480 cell viability by inducing cell apoptosis via caspase-3 activation and down-regulation of Bcl-2 expression. The present study provides scientific data that support the protective effect of silk sericin against cancer cells of the colon and suggests that this protein may have significant health benefits and could potentially be developed as a dietary supplement for colon cancer prevention.
Assuntos
Animais , Bovinos , Humanos , Apoptose/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Colo/efeitos dos fármacos , Neoplasias do Colo/patologia , Sericinas/farmacologia , Seda/química , Bombyx , Linhagem Celular Tumoral , Sobrevivência Celular , Colo/citologia , Neoplasias do Colo/metabolismo , Neoplasias do Colo/prevenção & controle , Mucosa Intestinal/citologia , Mucosa Intestinal/efeitos dos fármacos , Peso Molecular , Sericinas/químicaRESUMO
INTRODUCTION: Colorectal cancer (CRC) is an important pathology characterized by tumors in colorectal segments. Colonoscopy is the gold standard of CRC detection, but it is very expensive. Then, new methods are required for CRC screening to reduce mortality and improve the cost-benefit ratio. Objective: Evaluate the efficacy of a questionnaire (QSSA) based on signs and symptoms of CRC. METHODS: The QSSA was answered by 40 patients, before the colonoscopy procedure. The patients were divided into two groups: group I, with 20 patients showing positive result in the questionnaire, and group II, with 20 people showing negative result in the questionnaire. Colonoscopy was considered positive when presenting neoplasm or its precursor. The result was statistically analyzed by Fischer's exact test and sensitivity calculation. RESULTS: The results showed 14 positive and 26 negative colonoscopies. Group I had 9 positive and 11 negative colonoscopies and Group II, 5 positive and 15 negative (p=0.20) colonoscopies. The questionnaire presented sensitivity of 64.2%. CONCLUSION: The use of this questionnaire based on signs and symptoms of CCR alone was not effective in CCR screening. (AU)
INTRODUÇÃO: O câncer colorretal (CCR) é uma importante afecção caracterizada pela presença de tumores localizados no colón ou reto. A colonoscopia, padrão ouro na detecção do CCR, demanda alto custo. Assim, há necessidade de métodos de triagem eficazes, visando um melhor custo beneficio na diminuição da mortalidade do CCR. OBJETIVO: Avaliar a efetividade de um questionário de sinais, sintomas e antecedentes (QSSA) em predizer o CCR. Métodos: O QSSA foi aplicado a 40 pacientes, momentos antes da realização do exame colonoscópico, no intuito de compor dois grupos: grupo I formado pelos 20 primeiros que apresentassem o QSSA positivo, e grupo II formado pelos 20 primeiros com QSSA negativo. A colonoscopia positiva foi aquela com achado de neoplasia ou lesões precursoras do CCR. O resultado foi submetido à análise estatística através do Teste Exato de Fischer e do cálculo da sensibilidade, especificidade, acurácia e valores preditivos positivos e negativos. RESULTADO: Observaram-se 14 colonoscopias positivas e 26 colonoscopias negativas, assim distribuídas: grupo I, 9 positivas e 11 negativas; grupo II, 5 positivas e 15 negativas (p=0,20). O questionário apresentou sensibilidade de 64,2%. CONCLUSÃO: A utilização de um questionário de sinais, sintomas e antecedentes usado isoladamente não mostrou eficácia no rastreamento de lesões neoplásicas. (AU)
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Neoplasias Retais/prevenção & controle , Neoplasias do Colo/prevenção & controle , Detecção Precoce de Câncer/métodos , Inquéritos e Questionários , ColonoscopiaRESUMO
β-ionone (βI), a cyclic isoprenoid, and geraniol (GO), an acyclic monoterpene, represent a promising class of dietary chemopreventive agents against cancer, whose combination could result in synergistic anticarcinogenic effects. The chemopreventive activities of βI and GO were evaluated individually or in combination during colon carcinogenesis induced by dimethylhydrazine in 48 3-week-old male Wistar rats (12 per group) weighing 40-50 g. Animals were treated for 9 consecutive weeks with βI (16 mg/100 g body weight), GO (25 mg/100 g body weight), βI combined with GO or corn oil (control). Number of total aberrant crypt foci (ACF) and of ACF ≥4 crypts in the distal colon was significantly lower in the GO group (66 ± 13 and 9 ± 2, respectively) compared to control (102 ± 9 and 17 ± 3) and without differences in the βI (91 ± 11 and 14 ± 3) and βI+GO groups (96 ± 5 and 19 ± 2). Apoptosis level, identified by classical apoptosis morphological criteria, in the distal colon was significantly higher in the GO group (1.64 ± 0.06 apoptotic cells/mm²) compared to control (0.91 ± 0.07 apoptotic cells/mm²). The GO group presented a 0.7-fold reduction in Bcl-2 protein expression (Western blot) compared to control. Colonic mucosa concentrations of βI and GO (gas chromatography/mass spectrometry) were higher in the βI and GO groups, respectively, compared to the control and βI+GO groups. Therefore, GO, but not βI, represents a potential chemopreventive agent in colon carcrvpdate=20110329inogenesis. Surprisingly, the combination of isoprenoids does not represent an efficient chemopreventive strategy.